IGF2BP2 stabilized by USP7 promotes cancer-associated fibroblast activation and attenuates gemcitabine sensitivity in PDAC
Cell Reports · 2025-11 · 44 (11) · 116476
DOI: 10.1016/j.celrep.2025.116476 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2025-11. Verfasst von Fujing Ge und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacology & Toxicology, Zhejiang Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University…. Hauptthemen laut MEDLINE: Ubiquitin-Specific Peptidase 7, Deoxycytidine, Carcinoma, Pancreatic Ductal, RNA-Binding Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Key Research and Development Program of Zhejiang Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pharmacology & Toxicology, Zhejiang Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
- Innovation Institute for Artificial Intelligence in Medicine, Zhejiang University, Hangzhou, China.
- Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province, Zhejiang Provincial People's Hospital, Hangzhou, China.
- The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Center for Drug Safety Evaluation and Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
- Department of Cell Biology, Zhejiang University School of Medicine, Hangzhou, China.
Förderung
- Key Research and Development Program of Zhejiang Province
- National Natural Science Foundation of China
Zitieren
APA
Ge, F., Zhu, H., Liu, X., Li, Y., Guo, R., Zeng, C., Yuan, T., Yang, L., Dong, X., Wu, Y., Gai, R., Hu, R., Zhou, T., He, Q., Zhu, H., & Yang, B. (2025). IGF2BP2 stabilized by USP7 promotes cancer-associated fibroblast activation and attenuates gemcitabine sensitivity in PDAC. Cell Reports, 44(11), 116476. https://doi.org/10.1016/j.celrep.2025.116476
Vancouver
Ge F, Zhu H, Liu X, Li Y, Guo R, Zeng C, et al. IGF2BP2 stabilized by USP7 promotes cancer-associated fibroblast activation and attenuates gemcitabine sensitivity in PDAC. Cell Reports. 2025;44(11):116476. doi:10.1016/j.celrep.2025.116476
BibTeX
@article{Ge2025,
author = {Ge, Fujing and Zhu, Hongdao and Liu, Xiangning and Li, Yuekang and Guo, Runqiu and Zeng, Chenming and Yuan, Tao and Yang, Liu and Dong, Xin and Wu, Yulian and Gai, Renhua and Hu, Ronggui and Zhou, Tianhua and He, Qiaojun and Zhu, Hong and Yang, Bo},
title = {IGF2BP2 stabilized by USP7 promotes cancer-associated fibroblast activation and attenuates gemcitabine sensitivity in PDAC},
journal = {Cell Reports},
year = {2025},
volume = {44},
number = {11},
pages = {116476},
doi = {10.1016/j.celrep.2025.116476}
}
EUVIMED